Eye Mutant Resource
眼睛突变体资源
基本信息
- 批准号:7770341
- 负责人:
- 金额:$ 45.67万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-02-01 至 2015-01-31
- 项目状态:已结题
- 来源:
- 关键词:AnatomyAnimal ModelAuthorization documentationAwardBiological MarkersBiological ModelsCandidate Disease GeneCell physiologyChargeCollectionCommunitiesDNADNA MarkersDatabasesDefectDevelopmentDiseaseElectronicsElectroretinographyEngineeringEnsureEnvironmentExhibitsEyeEye diseasesFeesFutureGenesGeneticGenotypeGoalsGrantHumanIn SituInbred StrainInstitutesLaboratoriesLiteratureLocationMapsMethodsModelingMolecularMolecular ProfilingMusMutant Strains MiceMutationNatureOnline Mendelian Inheritance In ManOphthalmoscopyPathway interactionsPhenotypePhysiologyPositioning AttributeProtocols documentationPublicationsRecoveryResearchResearch PersonnelResourcesRetinalRetinal DiseasesRetinal NeovascularizationRoleScientistScreening procedureServicesSiteStructureStudy modelsSystemSystems AnalysisTechnical ExpertiseTechniquesTestingTherapeuticTimeUpdateVariantVision researchWorkanimal careclinical phenotypeclinically relevantcostdisease phenotypehuman diseaseimprovedinformation gatheringinterestmeetingsmouse modelmutantneovascularizationnovelprogramspublic health relevancerepositorysuccesstoolweb site
项目摘要
DESCRIPTION (provided by applicant): The main objective of the Eye Mutant Resource (EMR) is to identify, characterize, and preserve mice with genetically caused ocular disorders. Our purpose is to distribute these well-characterized models quickly and efficiently to support and promote vision research with the ultimate goal of advancing the elucidation, treatment, and cure of heritable eye diseases. Award of this grant is critical to the continuation of this unique resource. In this application, we will work toward enhancing the present EMR by developing robust genotyping protocols, fixing the genetic backgrounds of mutants to allow for comparison across mutations, cryo-preserving mutants to ensure their future availability, and improving the accessibility of the information in our EMR database. We will also increase the number of ocular mutants available to the research community two-fold during the grant period and continue our very successful screening program for new mutants with ocular diseases. Finally, we will complete the initial phenotypic and/or molecular characterization of ocular mutants previously identified, focusing initially on eight models exhibiting sub-retinal neovascularization. The models themselves and the information gathered on each mutant will be available to the research community through literature, electronic publications, and the updated EMR web site. It is expected that with the concerted effort and contribution from many groups using the EMR models, cumulatively, we will make a very significant impact on vision research.
PUBLIC HEALTH RELEVANCE: Models to study eye diseases that occur in humans are important as reproducible experimental systems for elucidating pathways of normal development and function. Further, these models can be used to identify treatment targets and to test therapeutic strategies. The EMR focuses on identifying, characterizing and distributing such models.
描述(由申请人提供):眼睛突变资源(EMR)的主要目的是识别,表征和保存遗传引起的眼部疾病的小鼠。我们的目的是快速有效地分发这些良好的模型,以支持和促进视觉研究,以推动阐明,治疗和治愈可遗传的眼部疾病的最终目标。这笔赠款的奖励对于继续这种独特资源至关重要。 在此应用程序中,我们将通过开发可靠的基因分型方案来增强当前的EMR,固定突变体的遗传背景,以允许在突变,冷冻的突变体之间进行比较,以确保其未来的可用性,并提高我们EMR数据库中信息的可访问性。在赠款期间,我们还将增加研究社区可用的眼突变体的数量,并继续为新的眼部疾病新突变体筛查计划。最后,我们将完成先前鉴定的眼突变体的初始表型和/或分子表征,最初集中在八种表现出下视视网膜新生血管形成的模型上。模型本身以及每个突变体上收集的信息将通过文献,电子出版物和更新的EMR网站提供给研究社区。预计,通过使用EMR模型的许多小组的共同努力和贡献,我们将对视力研究产生非常重大的影响。
公共卫生相关性:研究人类中发生的眼病的模型对于阐明正常发育和功能的途径的可再现实验系统很重要。此外,这些模型可用于识别治疗目标和测试治疗策略。 EMR专注于识别,表征和分发此类模型。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BO CHANG其他文献
BO CHANG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BO CHANG', 18)}}的其他基金
相似国自然基金
髋关节撞击综合征过度运动及机械刺激动物模型建立与相关致病机制研究
- 批准号:82372496
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
利用碱基编辑器治疗肥厚型心肌病的动物模型研究
- 批准号:82300396
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
利用小型猪模型评价动脉粥样硬化易感基因的作用
- 批准号:32370568
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
丁苯酞通过调节细胞异常自噬和凋亡来延缓脊髓性肌萎缩症动物模型脊髓运动神经元的丢失
- 批准号:82360332
- 批准年份:2023
- 资助金额:31.00 万元
- 项目类别:地区科学基金项目
APOBEC3A驱动膀胱癌发生发展的动物模型及其机制研究
- 批准号:82303057
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
相似海外基金
Neuroinflammation in Cerebral Small Vessel Disease using PET/MR Imaging
使用 PET/MR 成像研究脑小血管疾病的神经炎症
- 批准号:
10467487 - 财政年份:2022
- 资助金额:
$ 45.67万 - 项目类别:
Thin, High-Density, High-Performance, Depth and Surface Microelectrodes for Diagnosis and Treatment of Epilepsy
用于癫痫诊断和治疗的薄型、高密度、高性能、深度和表面微电极
- 批准号:
10294893 - 财政年份:2021
- 资助金额:
$ 45.67万 - 项目类别:
Thin, High-Density, High-Performance, Depth and Surface Microelectrodes for Diagnosis and Treatment of Epilepsy
用于癫痫诊断和治疗的薄型、高密度、高性能、深度和表面微电极
- 批准号:
10477274 - 财政年份:2021
- 资助金额:
$ 45.67万 - 项目类别:
Clinical efficacy of the antitumor agent ONC201 in GBM
抗肿瘤药物ONC201治疗GBM的临床疗效
- 批准号:
9405071 - 财政年份:2015
- 资助金额:
$ 45.67万 - 项目类别:
Clinical efficacy of the antitumor agent ONC201 in GBM
抗肿瘤药物ONC201治疗GBM的临床疗效
- 批准号:
9118605 - 财政年份:2015
- 资助金额:
$ 45.67万 - 项目类别: